Skip to main content

Earnings Review: AstraZeneca Increases Profit Outlook, Reports 17% EPS Growth

AstraZeneca reported an EPS of $1.73 for Q3 2023 and $5.8 for 9M 2023.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.